Release originally posted on Crain’s Chicago Business
Chicago-based sepsis diagnosing biotech Prenosis announced two $20 million milestones this morning, Series A financing and a large government contract.
Read full release >
Science
This can be a short description about this vertical and all the great links contained therein.
R&D Strategy
Evidence
Pipeline
Clinical Trials
Article originally published February 2026 […]
Learn More ›
Products
This can be a short description about this vertical and all the great links contained therein.
Sepsis ImmunoScore®
First-ever FDA authorized AI sepsis diagnostic tool with powerful diagnostic and predictive capabilities
5th World Sepsis Congress | […]
Learn More ›
Resources
This can be a short description about this vertical and all the great links contained therein.
Resource Library
Events
Sepsis ImmunoScore® demonstrates stronger predictive […]
Learn More ›
Newsroom
Read the latest Prenosis peer-reviewed articles and items from scholarly journals.
Newsroom
Sepsis ImmunoScore® demonstrates stronger predictive […]
Learn More ›
About
Read the latest Prenosis peer-reviewed articles and items from scholarly journals.
Mission, Vision, Values
Careers
Leadership
Awards
AI in Chicago | Episode […]
Learn More ›